US FDA | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Thursday
February 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
THURSDAY, FEBRUARY 02, 2023

US FDA

A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. Photo: Reuters
Coronavirus chronicle

US FDA authorizes Novavax Covid vaccine for adults

Photo: Collected
World+Biz

US approves first pill for treatment of alopecia

FILE PHOTO: An employee shows the Moderna coronavirus disease (Covid-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, US, December 21, 2020. REUTERS/Eduardo Munoz
Coronavirus chronicle

US CDC backs full approval of Moderna's Covid-19 vaccine

Paxlovid, a Pfizer's coronavirus disease (Covid-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021.  Photo :Reuters
Coronavirus chronicle

US FDA set to authorize Pfizer, Merck Covid-19 pills this week - Bloomberg News

FILE PHOTO: The headquarters of the US Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed
Coronavirus chronicle

US FDA lifts clinical hold on Inovio's Covid-19 vaccine trial

FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo
Coronavirus chronicle

US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
USA

US FDA gives marketing nod to an e-cigarette for the first time

Syringes filled with a dose of the Moderna Covid-19 vaccine sit on a table during an employee vaccination at the Sarasota Memorial Hospital in Sarasota, Florida, US, September 24, 2021. Photo :Reuters
Coronavirus chronicle

US FDA staff says Moderna did not meet all criteria for Covid-19 boosters

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

US FDA grants full approval to Pfizer-BioNTech Covid-19 vaccine

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Pfizer, BioNtech submit data to FDA for Covid-19 vaccine booster authorisation

FILE PHOTO: The headquarters of the US Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed
Coronavirus chronicle

US FDA authorises Covid-19 vaccine boosters for the immunocompromised

FILE PHOTO: The headquarters of the US Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed
World+Biz

US FDA approves Merck's Keytruda combo for early breast cancer treatment

The headquarters of the European Medicines Agency (EMA), is seen in London, Britain, 25 April, 2017/ Reuters
Coronavirus chronicle

EU reviews J&J Covid-19 shot for rare nerve disorder after US warning

  • Show More
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]